Skip to main content

All Content

Search Tips
Save
Selection
Format
Download
Published Date
Original Publication Date
Original Publication Date
PSNet Publication Date
Narrow Results By
PSNet Original Content
1 - 13 of 13
Piatek OI, Ning JC-min, Touchette DR. Am J Health Syst Pharm. 2020;7:1778-1785.
Drug shortages are an ongoing threat to safe patient care. This commentary discusses the impact of COVID-19 on medication supply and demand, and the resulting drug shortages. The authors provide several recommendations for reducing future drug shortages in times of crises, including increasing stockpiles and creating a critical drug list with potential substitutes.
Girion L, Levine D, Respaut R. Reuters. 2020;June 9.
The COVID-19 pandemic has disrupted the supply of protective equipment, medical devices and medications. This article discusses how economics contribute to drug shortages and highlights the specific impact on access to the opioids essential for providing safe care for hospitalized patients with COVID-19.
Fox ER, Sweet B, Jensen V. Mayo Clin Proc. 2014;89:361-73.
National drug shortages in the United States have become a serious patient safety concern. Spotlighting the impact of drug shortages on the economy and health care, this review reveals underlying issues contributing to the problem and highlights the persisting need for solutions to address them.
Washington, DC: United States Government Accountability Office; February 10, 2014. Publication GAO-14-194.
Reporting on the current state of the drug shortage problem and its causes, this publication examines FDA efforts to proactively identify potential shortages and recommends enhanced policies and procedures for data management to augment this work.
Tampa, FL: International Society for Pharmaceutical Engineering; June 2013.
This worldwide survey determined root causes and underlying issues contributing to drug shortages and provides recommendations for industry and regulators to drive improvement.

Hearings before the Subcommittee on Health of the Committee on Energy and Commerce Committee, 112th Cong, 1st Sess (September 23, 2011).

This hearing focused on the problem of medication shortages and its impact on patients, hospitals, and providers.